Movement Disorders

Papers
(The H4-Index of Movement Disorders is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
In Memoriam Mahlon R. DeLong (1938–2024)475
John Michael Walshe (April 24, 1920–October 14, 2022)157
Issue Information127
Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease123
Movement Disorders: Volume 40, Number 2, February 2025111
106
The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia93
Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism93
YY1: A New Gene for Childhood Onset Dystonia with Prominent Oromandibular‐Laryngeal Involvement?87
Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model87
Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait84
Classifying Idiopathic Rapid Eye Movement Sleep Behavior Disorder, Controls, and Mild Parkinson's Disease Using Gait Parameters82
Measuring Tremor—A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating79
The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?78
Stability of Mosaic Divergent Repeat Interruptions in X‐Linked Dystonia‐Parkinsonism74
A Multi‐center Genome‐wide Association Study of Cervical Dystonia73
X‐Linked Dystonia‐Parkinsonism (“Lubag”) May Present with Peripheral Synucleinopathy72
Fixel‐Based Analysis Reveals Whole‐Brain White Matter Abnormalities in Cervical Dystonia71
Deep Brain Stimulation of the Globus Pallidus Internus and Externus in Multiple System Atrophy68
α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property65
Bidirectional Transcription at the PPP2R2B Gene Locus in Spinocerebellar Ataxia Type 1264
The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease63
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials63
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease63
May Infographic63
Plasma Biomarkers and Positron Emission Tomography Tau Pathology in Progressive Supranuclear Palsy61
Mortality of People with Parkinson's Disease in a Large UK‐Based Cohort Study: Time Trends and Relationship to Disease Duration60
Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [18F]‐FEMPA PET Study60
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure58
Clinical Utility of 18F‐APN‐1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy57
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers57
Movement Disorders: Volume 37, Number 9, September 202256
Adaptive Deep Brain Stimulation: From Experimental Evidence Toward Practical Implementation56
Obituary for Jan O. Aasly (1950–2022)56
Author Index53
Movement Disorders: Volume 36, Number 11, November 202153
October Infographic52
52
Thank you to Reviewers 202251
Issue Information51
Novel In‐Frame FGF14 Deletion Causes Spinocerebellar Ataxia Type 27A: Clinical Response to Deep Brain Stimulation and 4‐Aminopyridine50
Central Involvement in Pure Autonomic Failure: Insights from Neuromelanin‐Sensitive Magnetic Resonance Imaging and 18F‐Fluorodopa‐Positron Emission Tomography50
Downbeat Nystagmus in Episodic Ataxia Type 1 Associated with a Novel KCNA1 Mutation48
Parkinson's Disease Modification Through Abl Kinase Inhibition: An Opportunity48
Effect of Public Interest in Magnetic Resonance Imaging–Guided Focused Ultrasound on Enrolment for Deep Brain Stimulation46
Reply to: “Application of the mPSPRS to the Salerno Cohort”46
Diagnostic and Prognostic Value of External Anal SphincterEMGPatterns in Multiple System Atrophy46
0.10693097114563